SCHEMBL8370875

SCHEMBL8370875

CC1(C)CC(=O)Cc2cc(Br)ccc21

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 3/20 0.47
CMA1 P23946 1/20 0.46
AHR P35869 1/20 0.46
BRD4 O60885 1/20 0.41
METAP1 P53582 1/20 0.41
PDE4B Q07343 1/20 0.38
PGR P06401 2/20 0.38
PARP1 P09874 2/20 0.36
ALDH1A1 P00352 1/20 0.34
PARP10 Q53GL7 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PARP11 Q9NR21 1/20 0.33
ADRA2A P08913 1/20 0.33
PNMT P11086 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7796330 0.88 CMA1 (0.47) TDP2CMA1AHRBRD4METAP1
SCHEMBL9419023 0.85 TDP2 (0.42) TDP2CMA1AHRBRD4METAP1
SCHEMBL9418964 0.80 CMA1 (0.42) TDP2CMA1AHRBRD4METAP1
SCHEMBL9418949 0.76 CMA1 (0.42) TDP2CMA1AHRBRD4METAP1
SCHEMBL3574684 0.75 TDP2 (0.54) TDP2CMA1AHRBRD4METAP1
SCHEMBL1871781 0.74 HTR2A (0.50) TDP2AHRALDH1A1
SCHEMBL2591523 0.73 METAP1 (0.52) TDP2CMA1AHRBRD4METAP1
SCHEMBL484599 0.71 PDE4B (0.46) TDP2CMA1AHRPDE4BPGR
SCHEMBL9418976 0.71 ALDH1A1 (0.39) TDP2CMA1AHRBRD4PDE4B
SCHEMBL2223847 0.71 KDM1A (0.43) TDP2CMA1AHRBRD4METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0948478-A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY Allergan Sales, Inc. (US) 1999-10-13 EP disclosed
WO-1998025875-A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES, INC. (US) 1998-06-18 WO disclosed